Testis transcriptome analysis in male infertility: new insight on the pathogenesis of oligo-azoospermia in cases with and without AZFc microdeletion by Gatta, Valentina et al.
Gatta et al. BMC Genomics 2010, 11:401
http://www.biomedcentral.com/1471-2164/11/401
Open Access RESEARCH ARTICLE
© 2010 Gatta et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Testis transcriptome analysis in male infertility: 
new insight on the pathogenesis of 
oligo-azoospermia in cases with and without AZFc 
microdeletion
Valentina Gatta†1,2, Florina Raicu†3,4, Alberto Ferlin†5, Ivana Antonucci1,2, Anna Paola Scioletti2,4, Andrea Garolla5, 
Giandomenico Palka1,6, Carlo Foresta5 and Liborio Stuppia*1,2,7
Abstract
Background: About 10% of cases of male infertility are due to the presence of microdeletions within the long arm of 
the Y chromosome (Yq). Despite the large literature covering this critical issue, very little is known about the 
pathogenic mechanism leading to spermatogenesis disruption in patients carrying these microdeletions. In order to 
identify the presence of specific molecular pathways leading to spermatogenic damage, testicular gene expression 
profiling was carried out by employing a microarray assay in 16 patients carrying an AZFc microdeletion or affected by 
idiopathic infertility. Hierarchical clustering was performed pooling the data set from 26 experiments (16 patients, 10 
replicates).
Results: An intriguing and unexpected finding is that all the samples showing the AZFc deletion cluster together 
irrespectively of their testicular phenotypes. This cluster, including also four patients affected by idiopathic infertility, 
showed a downregulation of several genes related to spermatogenesis that are mainly involved in testicular mRNA 
storage. Interestingly, the four idiopathic patients present in the cluster showed no testicular expression of DAZ despite 
the absence of AZFc deletion in the peripheral blood.
Conclusions: Our expression profiles analysis indicates that several forms of infertility can be triggered by a common 
pathogenic mechanism that is likely related to alterations in testicular mRNA storage. Our data suggest that a lack of 
testicular DAZ gene expression may be the trigger of such mechanism. Furthermore, the presence of AZFc deletions in 
mosaic or the loss of function of AZFc genes in absence of Yq deletion can perhaps explain these findings. Finally, 
based on our data, it is intriguing to hypothesize that DAZ gene dysfunctions can account for a larger number of 
previously thought "idiopathic" infertility cases and investigation of such testicular gene dysfunction can be important 
to reveal the molecular determinant of infertility than are undetected when only testing Yq deletions in peripheral 
blood.
Background
Microdeletions of the Y chromosome long arm (Yq) rep-
resent the main molecular determinants of male infertil-
ity and account for about 10% of cases of non obstructive
azoospermia or severe hypospermatogenesis [1-5]. Yq
microdeletions involve three Azoospermia Factors (AZF)
loci, AZFa, AZFb and AZFc [6] and remove many genes
likely involved in male germ cell development and main-
tenance [7]. The most frequent deletion of the Y chromo-
some (AZFc, b2/b4) spans 3.5 Mb and eliminates 21
genes and transcription units of the AZFc region. Among
these, the main candidate for spermatogenesis failure is
the Deleted in Azoospermia (DAZ) gene, a testis specific
gene present in four copies within AZFc and encoding for
an RNA binding protein [6,7]. The AZFc deletion has
been associated with wide range of phenotypes ranging
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from the complete absence of germ cells in the testes
(Sertoli cell only syndrome, SCOS) to a relevant reduc-
tion of germ cells still including mature sperm (severe
hypospermatogenesis, HS), to a maturation spermato-
genesis arrest. Despite the large number of studies inves-
tigating the prevalence and the molecular basis of these
rearrangements, the testicular gene expression of patients
carrying Yq deletions is still largely unknown and so are
the molecular mechanisms leading to spermatogenesis
disruption.
In recent years, expression profiling of human testis has
been widely used for the identification of genes that are
involved in different key steps of testis development and
function [8-10]. However, at the moment, not a single
study has investigated the testicular transcriptome of
patients who carry Yq microdeletions.
In this study, we analyzed testis expression profiles of
16 infertile patients with different testicular phenotypes,
including men carrying AZFc deletions as well as subjects
with idiopathic infertility.
Results
In order to discriminate the genes specifically involved in
the different pathological phenotypes, we performed a
hierarchical clustering of the data set originated from 26
experiments (16 patients, 10 technical replicates) (Table
1). All the AZFc samples clustered together indepen-
dently from their testis phenotype (SCOS or HS) (Figure
1). The same cluster also contained 4 patients without Yq
deletions (3 affected by idiopathic HS and one by idio-
pathic SCOS). The remaining three patients without Yq
deletions showed a different gene expression profile
which was not clustered together with AZFc deleted
patients. All the testes with normal spermatogenesis clus-
tered appropriately into their group. The cluster contain-
ing AZFc-deleted samples was characterized by the
presence of 490 transcripts showing at least a 1.7-fold
change in expression as compared to testis with normal
spermatogenesis (Additional file 1 and 2). Semiquantita-
tive RT-PCR, carried out on selected genes (ACTL7B,
LDHC, ODF 1, TSSK2, PRM2, TNP1), confirmed
microarray results (additional file 3).
Ingenuity Pathway Analysis (IPA) was carried out to
investigate the main functions played by genes that were
found to be downregulated (n. = 331, additional file 1)
and showed that "Cellular development" and "Reproduc-
tive system development and function" were the main
functions correlated with these genes (Figure 2). These
functional categories contained several genes playing a
role in spermatogenesis, fertilization, and determination
of the testicular mass, some of which are involved in
human and murine male infertility (DDX25 and FKBP6)
[11] (SPAG6) [12] (Table 2).
When we analyzed the upregulated genes (n = 159,
additional file 2), IPA showed that "Cellular growth and
proliferation" and "Cell death" were the functions to be
involved, whereas "Reproductive system development
and function" was less represented (Figure 3, Table 3).
Network analysis of the dowregulated genes that are
linked with spermatogenesis showed an interesting net-
work centered on the YBX2 (MSY2) gene, a member of
the Y-box gene family that is selectively expressed in male
and female germ cells (Figure 4) [13]. We also found an
additional network that is centered on the ARNT2 gene
and contains other genes critically involved in the sper-
matogenetic process (CRISP2, TSSK2, MDM4 and EGR4)
(Figure 5).
A specific analysis of the DAZ gene signal in the sam-
ples represented in the cluster showed that DAZ was not
expressed in all the four patients who were not carrying
the AZFc deletion (Table 4). These results were con-
firmed by a RT-PCR analysis carried out as previously
described [14]. The same kind of analysis was carried out
also for CDY1 and VCY2 genes, mapped in multiple cop-
ies within AZFc locus close to the DAZ gene cluster [7].
This analysis evidenced CDY1 expression in patients with
idiopathic infertility but not in those with AZFc deletion.
On the other hand, an overexpression of VCY2 gene was
d e t ect ed  i n  4  o u t  o f  6  pa t i e n ts  wi t h  A ZF c  d e l e t i o n .  A
BLAST search using the VCY2 oligonucleotide sequence
spotted on the array discovered a 60% homology with the
sequence mapped in Yp, corresponding to a portion of
the VCY2 exon 7, in addition to the expected 100%
homology with VCY2 coding region.
Discussion
In the present study, we carried out a microarray analysis
to investigate testicular gene expression profiles in
patients affected by different forms of infertility. Due to
the absence or reduced number of germ cells in these
patients, a downregulation of genes with prominent or
exclusive germ cell expression was expected in all sam-
ples, whereas genes expressed mainly in somatic cells
were expected to show increased expression. However,
the main purpose of this study was to analyze the inter-
individual differences among infertile patients, in order
to identify specific expression profiles for each different
conditions.
Using this approach we found a similar gene expression
profile in all the samples originated from individuals car-
rying the AZFc deletion as well as in four patients with
idiopathic infertility. All these case showed a common
gene cluster that contained 490 transcripts (331 down-
and 159 upregulated genes). Since all HS patients had the
same Johnsen score, the difference in the expression pro-
files of samples present in the cluster and patients outsideGatta et al. BMC Genomics 2010, 11:401
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Figure 1 Hierarchical clustering showing a similar expression profile in all patients with AZFc deletions and in four patients with idiopathic 
infertility. In the figure, all the relevant genes are grouped according to their expression values shown as log ratios (ratios are: gene expression value 
of the pathological testis divided by the value of a normal testis and values of the three samples with normal spermatogenesis divided by the home-
made RNA universal). Each row corresponds to one gene, each column to different 26 microarray experiments. The quantitative changes in gene ex-
pression across all the samples are represented in color: red indicates overexpressed genes, and green indicates downregulated genes. Black bars in-
dicate no changes in expression. Missing data points are represented as gray bars. Different colors of top labels indicate different testis phenotypes. 
(Pink= idiopathic SCOS; red = AZFc microdeletion with SCOS phenotype; green = idiopathic HS; blue = AZFc microdeletion with HS phenotype; purple 
= normal testis; R= replica).Gatta et al. BMC Genomics 2010, 11:401
http://www.biomedcentral.com/1471-2164/11/401
Page 4 of 10
the cluster cannot be due to a different number of germ
cells in their testis, but likely indicates a real difference in
the transcription levels of specific genes. Among the
downregulated transcripts, we detected several genes
involved in spermatogenesis, fertilization, and male infer-
tility. To clarify a potential pathogenic link between the
downregulation of these transcripts and spermatogenesis
failure, we carried out an IPA network analysis that
revealed two interesting networks. The first network is
centered on the YBX2 (MSY2) gene, a member of the Y-
box gene family that is specifically expressed in male and
female germ cells. YBX2 marks specific mRNAs for cyto-
plasmic storage, stabilization, and suppression of transla-
tion [13]. RNA storage is a crucial step during
spermatogenesis. RNA synthesis terminates during mid-
spermiogenesis and stabilization and storage of mRNAs
are key for the encoding of proteins needed during the
terminal phases of spermatogenesis [15]. Quite surpris-
ingly, network analysis of the cluster of patients carrying
AZFc deletions showed that YBX2 was not present in the
cluster, being not significantly downregulated in the sam-
ples within the cluster as compared to the other samples
not present in the cluster. However, several genes whose
activity is regulated by YBX2 were found to be downex-
pressed in the network. Among these, we found ODF1,
TNP1 and PRM2, all genes that play a key role in the
postmeiotic phase of the spermatogenesis. ODF1
encodes for proteins located on the outside of the
axoneme in the mid piece and principal piece of the
mammalian sperm tail, thereby maintaining the passive
elastic structures and elastic recoil of the sperm tail.
TNP1 is a spermatid-specific product of the haploid
Table 1: Testis phenotype of the investigated patients and number of micorarray experiments.
Patients classification Semen analysis Testis histology (Johnsen score) Patient ID Microarray
experiments
Idiopathic SCOS Azoospermia SCOS (2) 1 1
Idiopathic HS ≤ 1 × 106/ml Severe HS (8) 2 3
32
41
51
61
71
AZFc microdeletion SCOS Azoospermia SCOS (2) 8 4
92
AZFc microdeletion HS ≤ 1 × 106/ml Severe HS (8) 10 1
11 1
12 2
13 3
Obstructive azoospermia Azoospermia Normal spermatogenesis (10) 14 1
15 1
16 1
Total microarray experiments 26
Figure 2 Histogram showing the main biological functions of 
downregulated genes present in the cluster of patients with AZFc 
deletion.Gatta et al. BMC Genomics 2010, 11:401
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genome which replaces histones and is itself replaced in
the mature sperm by the protamines. PRM2 encodes for
proteins playing a key role in DNA packaging during
sperm differentiation. The combined downregulation of
all these genes suggests reduced storage of these tran-
scripts during spermatogenesis, via a YBX2-independent
process as the YBX2 transcript was not found within the
cluster. A possible intriguing hypothesis is that the loss of
function of the DAZ gene, the most important gene dis-
rupted by AZFc deletions [16], leads to a pathogenic
defective mRNA storage. Substantiating this idea, RNA-
binding proteins encoded by DAZ  are known to be
required for the translational regulation of gene expres-
sion that is essential for gametogenesis [17,18]. Further-
more, it has been showed that Dazl, the murine
homologous of DAZ, plays a role in the transport of spe-
cific mRNAs via a dynein motor complex, and that the
Dazl-bound mRNAs is stored at specific sites to be avail-
able and used for later developmental processes [19].
Therefore we hypothesize that DAZ disruption may rep-
resent a possible cause of the reduced storage of impor-
tant testis transcripts encoded in the first steps of the
spermatogenesis.
Interestingly, the second network we analyzed is cen-
tered on the ARNT2  gene and contains several genes
involved in the spermatogenesis process (CRISP2, TSSK2,
MDM4 and EGR4). CRISP2 is a testis-enriched protein
localized to the sperm acrosome and tail. TSSK2 encodes
a testis-specific serine/threonine kinase and is bound by
the human and murine forms of DAZL. EGR4 is a mem-
ber of the Egr family of zinc-finger transcription factors,
and regulates genes critically involved in the early stages
of meiosis. Thus, it is intriguing to conceive that also
ARNT2 may play an important role in the pathogenesis of
infertility in AZFc deleted patients.
The microarray analysis of samples from patients with
AZFc deletion also showed the presence of 159 upregu-
lated transcripts. It is interesting to note that only a few of
these genes have been previously linked to infertility.
A2M, a gene that is encoding for a protease inhibitor, is
up-regulated in the testis of the ABP transgenic mouse
that shows an impairment of spermatogenesis [20].
Increased expression of HIF1A, an hypoxia-inducible
transcription factor, is present in the internal spermatic
vein of patients with varicocele [21]. Finally, HMGB1,
encoding for a high mobility group protein, works as a
pro-inflammatory and antibacterial factor in human tes-
tis [22]. These data suggest that the overexpression of
genes related to cell growth and proliferation as well as to
a po pt osis i n t he t es tis  of  pa t ie n ts wit h AZF c de let ions
may represent an unspecific mechanism of reaction to
testis damage, rather than the cause of defective sper-
matogenesis.
An unexpected finding of the present study is that the
four patients without AZFc deletion are included in the
same cluster containing samples from AZFc deleted
patients. In order to verify if the presence of an intact
AZFc region in peripheral blood actually correlates with a
normal testicular DAZ expression, we focused our atten-
tion to the presence/absence of the specific signals for
this gene on the array in all cases contained in the cluster.
Interestingly, no DAZ signal was detected in any of the
four patients without AZFc deletion. Lack of DAZ
expression was expected in the samples from patients
affected by idiopathic SCOS, due to the absence of germ
cells, but it was surprisingly found in the 3 patients
affected by idiopathic HS.
The lack of DAZ expression in the testis of infertile
patients who are not carrying the AZFc deletion in their
peripheral blood has been previously reported and inter-
Table 2: Dowregulated genes in the cluster containing AZFc deleted samples as classified on the basis of their main 
biological functions.
General biological function Specific biological function Downregulated genes in AZFc deleted patients cluster
Cellular development Spermatogenesis AFF4, CCT6B, CRISP2, DDX25, FKBP6, KIF6, PRM2, SPAG6, TNP1, TSGA10
Reproductive system development and 
function
Fertilization CLGN, DAZ1, TNP1, PCSK4
Mass of testis ARL4A, PTDSS2
Figure 3 Histogram showing the main biological functions of up-
regulated genes present in the cluster of patients with AZFc dele-
tion.Gatta et al. BMC Genomics 2010, 11:401
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preted as the result of somatic AZFc rearrangements pro-
ducing a mosaic in which Yq deletion is present only in
testicular cells [14,23]. Our results strongly confirm this
finding, corroborating the hypothesis that a portion of
patients classified as affected by idiopathic infertility
actually lack DAZ gene expression in their testis, thus
showing a pathogenic mechanism similar to the one
responsible of infertility in AZFc deleted patients. In
order to investigate also other AZFc genes, we analyzed
the specific spots for CDY1 and VCY2, in order to verify
their expression in patients with and without AZFc dele-
tion. As expected, CDY1 was expressed in infertile
patients without AZFc deletion independently fromtheir
collocation with or without the cluster, but not in patients
with AZFc deletion. On the other hand, expression levels
showed by VCY2 gene were inconsistent with those of
DAZ and CDY1 genes, being this gene overexpressed in 4
out of the 6 patients with AZFc deletion. In order todis-
close the cause of this unexpected result, we performed a
Blast search using the VCY2 oligonucleotide sequence
spotted on the array, discovering a 60% homology with a
sequence mapped within Yp, in addition of the expected
100% homology with VCY2 gene. This Yp sequence
matched with the VCY2 exon 7, target of the VCY2 probe
present in the array. On the other hand, DAZ and CDY1
probes showed homology only with their target genes.
This suggests that the VCY2 oligonucleotide on the array
is not specific enough to consider the expression levels of
this gene in the context of the present study.
Table 3: Upregulated genes in the cluster containing AZFc deleted samples as classified on the basis of their main 
biological functions.
General biological function Specific biological function Upregulated genes in AZFc deleted patients cluster
Cellular growth and proliferation Proliferation of eucariothic cell A2M, ADAMTS1, AIF1, ANGPTL1, CEBPD, COL4A1, DCN, GSTM1, 
HIF1A, HMGB1, ICMT, IL6ST, KIF3A, LY96, NKX3-1, PLAU, PTK2, 
S100B, SOD2, SPTBN1, TPT1
Reproductive system development and 
function
Reproductive process of mammalia DDX3Y (DBY), IL6ST, PLAU, UTY
Cell death apoptosis of eukaryotic cells A2M, ANGPTL1, C7, CEBPD, DCN, HIF1A, HMGB1, ICMT, IL6ST, 
KIF3A, PLAU, PTK2, SOD2, TPT1, YES1
Figure 4 IPA-originated network of downregulated genes found 
in the cluster of patients with AZFc deletion. Network centered on 
YBX2 gene. The grey shading indicates genes that show decreased ex-
pression in the pathological testis when compared with normal testis 
samples.
Figure 5 IPA-originated network involving of upregulated genes 
found in the cluster of patients with AZFc deletion. Network cen-
tered on ARNT2 gene. The grey shading indicates genes that show in-
creased expression in the pathological testis when compared with 
normal testis samples.Gatta et al. BMC Genomics 2010, 11:401
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Conclusions
In summary, our study provides the following novel infor-
mation: i) all patients with AZFc deletions show a similar
testis gene expression profile, independently from their
SCOS or HS phenotype, suggesting that all AZFc dele-
tions produce a similar transcriptional pattern and that
variability in phenotypes is related to environmental or
other genetic mechanisms. ii) one half of the patients
with idiopathic infertility cluster together with patients
with AZFc deletions, suggesting a common pathogenic
mechanism. We hypothesize that a crucial link that can
explain this phenomenon is the lack of expression of the
DAZ gene in the testes these cases. A potential alterna-
tive explanation may be related to the presence of an
AZFc deletion in mosaic and/or the loss of function of
AZFc genes in absence of Yq deletion. If our finding will
be confirmed on larger series of patients, DAZ gene dys-
functions may be proved to account for a larger portion
of cases of infertility than one could expect by simply ana-
lyzing the prevalence of Yq deletions among these sub-
jects; iii) we found that several genes that are mainly
related to the postmeiotic phase of the spermatogenesis
and have been previously reported as involved in male
infertility are dowregulated in patients with AZFc dele-
tions. Given the crucial role played by RNA storage dur-
ing spermatogenesis, the loss of function of DAZ  can
translate to a defective mRNA storage in testis with great
pathogenic implications. The identification of the molec-
Table 4: Expression of the DAZ gene in the investigated patients as evidenced by microarray analysis. + = presence of 
expression. - = absence of expression.
Patient ID Phenotype Present in the cluster DAZ expression
1 Idiopathic SCOS Yes -
2 Idiopathic HS No +
3 Idiopathic HS No +
4 Idiopathic HS No +
5 Idiopathic HS Yes -
6 Idiopathic HS Yes -
7 Idiopathic HS Yes -
8 AZFc deletion SCOS Yes -
9 AZFc deletion SCOS Yes -
10 AZFc deletion HS Yes -
11 AZFc deletion HS Yes -
12 AZFc deletion HS Yes -
13 AZFc deletion HS Yes -
14 Normal spermatogenesis No +
15 Normal spermatogenesis No +
16 Normal spermatogenesis No +Gatta et al. BMC Genomics 2010, 11:401
http://www.biomedcentral.com/1471-2164/11/401
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ular mechanisms underlying the spermatogenesis failure
in cases characterized by DAZ loss of function will pro-
vide useful information for the disclosure of key mole-
cules which could represent in the future the target for
personalized drug therapy.
Methods
Patients
The study was approved by the local Ethics Committee of
the University of Padova and was in accordance with the
Helsinki II Declaration. All participants were asked for
and provided their informed consent. The study popula-
tion was selected from a cohort of 1436 men presenting
idiopathic non obstructive azoospermia or severe hypos-
permatogenesis (sperm count <2 million/ml) [5]. Exclu-
sion criteria were: drug consumption, fever in the
previous 6 months, seminal infections, varicocele, sys-
temic diseases, previous cryptorchidism or orchitis, pres-
ence of anti-sperm auto-antibodies, hypogonadotrophic
hypogonadism, abuse of androgenic (anabolic) steroids,
treatment with chemotherapeutic agents or radiotherapy,
testicular tumors, karyotype abnormalities, androgen
receptor, INSL3 and RXFP2 gene mutations [24,25].
Semen analysis was performed according to the World
Health Organization guidelines [26] on at least two occa-
sions separated by three months. The diagnosis of azoo-
spermia was established by pellet analysis after semen
centrifugation.
The testicular structure and spermatogenic activity was
evaluated with a combination of methods to have the
most homogeneous sampling. As a screening procedure,
bilateral testicular fine needle aspiration (FNA) was per-
formed as previously described [5,27]. Testicular pheno-
type was classified as follows (1) Sertoli cell only
syndrome (SCOS): complete absence of all germ cells in
both testes; (2) hypospermatogenesis (HS): quantitative
reduction in the number of germs cells with still presence
of mature spermatozoa; and (3) maturation arrest (MA):
n o r m a l  p r e s e n c e  o f  g e r m  c e l l s  u n t i l  a  d e f i n i t e  s t e p  o f
spermatogenesis and lack of germ cells in the later stages.
Patients showing normal karyotype were submitted to
molecular testing for Yq microdeletions as previously
described (5). Only men carrying the AZFc-b2/b4 dele-
tion were included in the microarray analysis.
The final selected sample comprised 16 patients (pats.
1-16): one patient (pat. 1) had idiopathic SCOS, 6 patients
(pats. 2-7) had idiopathic severe HS, 3 patients (pats. 8-
10) had SCOS and AZFc-b2/b4 deletion, and 3 patients
(pats. 11-13) had severe HS and AZFc-b2/b4 deletion.
Three men with obstructive azoospermia and normal
spermatogenesis were used as controls (pats. 14-16) (Tab.
1).
Testicular histology
Selected subjects underwent bilateral testicular biopsy to
clearly assess testicular histology and provide RNA for
microarray experiments. At least three 3-5 mm fragments
per testis were excised, processed for histological analy-
sis, and at least one sample per testis was submerged in 2
ml of RNAlater (Ambion, Austin, TX, USA). Only biopsy
specimens showing a homogeneous histopathology of the
testis parenchyma and samples yielding high-quality total
RNA preparation were included in the analysis. Testicular
histology was classified using a modification of the classi-
cal scoring procedure employed by Johnsen [28] as: (1)
biopsies obtained from patients with post-testicular
obstructions showing complete spermatogenesis, i.e. all
stages represented and >20 late spermatids (also referred
as "testicular spermatozoa") per seminiferous tubule
(score count 10); (2) biopsies showing severe HS in all
seminiferous tubules (score count 8); (3) biopsies from
patients with SCOS (score count 2).
Microarray analysis
Testis samples were homogenized using an hand glass
potter, and total testis RNA extracted using the SVtotal
RNA Izolation System kit (Promega, Madison, WI, USA).
The purity and quantity of RNA was assessed using the
Agilent 8453 Spectrophotometer (Agilent, Santa Clara,
CA, USA). RNA quality was determined by both evalua-
tion of the integrity of rRNA bands using agarose electro-
phoresis, and absorbtion readings at 260 and 280 nm.
Extracted RNA was linearly amplified using the Amino
Allyl MessageAmp™ II aRNA Amplification Kit (Ambion,
Austin, TX, USA).
Five to ten ug of amplified aRNA was fluorescently
labelled with Cy3-Cy5 cyanins and then hybridizated on
high-density array (Microcribi Padova, Italy). The
Human Array Ready Oligo Set Version 2 contains array
able 70mers representing 21,329 well-characterized
human genes in two replicates from the UniGene Data-
base. This database is located at the National Center for-
Biotechnology Information (see http://
www.ncbi.nlm.nih.gov/UniGene/). The UniGene data-
base automatically clusters all human GenBank
sequences into a non-redundant set of genes. Each cluster
in the UniGene Database represents one unique gene. A
cluster may contain manysequences, but one representa-
tive sequence has been selected based on the longest
region of high-quality sequence data. All pathological tes-
tis RNAs were hybridized against normal testis RNA
samples (patients with obstructive azoospermia and nor-
mal spermatogenesis) while the three samples with nor-
mal spermatogenesis were hybridized against an home-
made RNA universal reference (brain, liver, muscle andGatta et al. BMC Genomics 2010, 11:401
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lung), to generate a profile of genes specifically expressed
in normal testis, for a total of 26 experiments (tab. 1).
After hybridization, Cy3-Cy5 fluorescent signals were
captured by a Confocal Laser Scanner "ScanArray
Express" (Packard BioScience) and analysed using the
software "ScanArray Express - MicroArray Analysis Sys-
tem" version 3.0  (Perkin Elmer). Raw data of the per-
f o r m e d  e x p e r i m e n t s  h a v e  b e e n  r e c o r d e d  i n  t h e  G E O
public database (accession number: GSE14310).
The values of the median signal intensity from each
spot were subtracted from the local median background
intensity. For each slide after local background subtrac-
tion, a LOWESS algorithm was used for row data normal-
ization to evaluate signal to noise ratio and generate log
ratios of sample vs. reference signal. Only spots showing a
signal to noise ratio of at least 1.7 were included in the
analysis.
Analysis of da ta obtained by microarra y experiments
was carried out by means of hierarchical gene clustering
[29] using Cluster 3.0 (open source 2006) and TreeView
(Stanford University Labs) software. In order to include
in clustering analysis only well measured transcripts, we
selected spots with a present call (identified transcripts
wit h m eas ur a b le  e x pr ess ion)  in a t l east  80% o f  e x pe ri-
ments and being > 1.7 fold up- or down regulated in at
least 8 experiments. Identified clusters were then ana-
lyzed by the Ingenuity Pathways Analysis (IPA) software
(Ingenuity Systems, Redwood City, CA), in order to clas-
sify genes based on their biological functions and disclose
the functional networks connecting specific genes.
Web Resources
Microarray data are deposited in the GEO public data-
base and are accessible without restriction at the follow-
ing URL: http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?token=bhqhdyekysokofq&acc=GSE14310 (accession
number: GSE14310).
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